Thoracic oncology
Grand round
Lung cancer Grand Round
Clinical
Aims : In this lung cancer Grand Round, four assembly members will challenge your knowledge in lung cancer care with their individual cases. This Grand Round will also provide you with a unique opportunity for interactive discussions with not only the case presenters but also an on-stage multidisciplinary board panel. Learn and debate about the following four hot lung cancer topics: using the full diagnostic potential of computed tomography (CT) lung cancer screening beyond the nodule; reappraising N2 disease in the era of immunotherapy and targeted therapies; controlling stage IV non-small cell lung cancer (NSCLC) with modern molecular diagnostics and systemic therapies; and tackling brain metastases and the primary tumour.
Target audience :
Clinical researcher, Critical/Intensive care physician, General practitioner, Lung function technologist, Nurse, Pathologist, Patient, Physiotherapist, Radiologist, Scientist (basic, translational), Student, Thoracic oncologist, Thoracic surgeon, Trainee, Adult pulmonologist/Clinician
Methods :
Cell and molecular biology, Endoscopy and interventional pulmonology, Epidemiology, General respiratory patient care, Imaging, Public health, Pulmonary function testing, Respiratory intensive care, Surgery
08:30
A benign nodule in former smoker with COPD
M. Afonso(Coimbra, Portugal)
COI
1
240
09:00
To resect, or not to resect – the problem with difficult histology and rare tumours
M. Esch(Ganderkesee, Germany)
COI
2
241
09:30
Intercalating multimodal treatment strategy in a patient with advanced pulmonary adenocarcinoma harbouring the uncommon complex EGFR mutation L833V/H835L
A. Frille(Leipzig, Germany)
COI
3
242
10:00
When you hear hoofbeats, look for zebras
J. van Meerbeeck(Edegem (Antwerp), Belgium)
COI
4
243
. . .
